Target-Specific Binding of Immunoliposomes in Vivo

Abstract
My group at the University of Tennessee has been concentrating on using monoclonal antibody to target a liposomal drug carrier system (1). Our initial effort to target these liposomes uses an organ-specific monoclonal antibody (for a preliminary account, see 2).